mortality/aging
• mice have increased mortality following treatment with a CD3epsilon antibody
• mortality increases following treatment with staphylococcal enterotoxin A (SEA)
• however, treatment with CD3epsilon antibody or staphylococcal enterotoxin A (SEA) and a COX-2 inhibitor reverses the increase in mortality
|
immune system
• treatment with a CD3epsilon antibody leads to inflammation of the cecum
|
• 2 hours after CD3epsilon antibody treatment, interferon-gamma levels are increased
|
• 8 hours after CD3epsilon antibody treatment, IL-6 levels are increased
|
• 2 hours after CD3epsilon antibody treatment, TNF-alpha levels are increased
|
• mortality increases following treatment with staphylococcal enterotoxin A (SEA)
|
digestive/alimentary system
• treatment with a CD3epsilon antibody leads to increased gastrointestinal damage in the cecum including mucosal and submucosal edema and inflammation along with necrotic regions that are denuded of mucosa
|
• treatment with a CD3epsilon antibody leads to inflammation of the cecum
|
homeostasis/metabolism
• 2 hours after CD3epsilon antibody treatment, interferon-gamma levels are increased
|
• 8 hours after CD3epsilon antibody treatment, IL-6 levels are increased
|
• 2 hours after CD3epsilon antibody treatment, TNF-alpha levels are increased
|